MET and gastric cancer: Though MET amplification accounts for only small part of total GC patients42,43, it is the most common of MET gene alteration, which leads to a poor disease-free survival in GC (Supplement Fig. 2C, D). MET amplification induces highly phosphorylated state of c-Met, which could activate several intracellular signaling pathways without HGF18.